Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.0K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.0K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

887
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
887
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

472
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
472
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monitoring rFVIIa 90 μg kg⁻¹ dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6 h.

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same author

Re: Discordant pair analysis of rFVIIa and pd-aPCC response.

Haemophilia : the official journal of the World Federation of Hemophilia·2011
Same author

Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.

Haemophilia : the official journal of the World Federation of Hemophilia·2007
Same author

Percutaneous liver biopsy in adult haemophiliacs with hepatitis C virus: safety of outpatient procedure and impact of human immunodeficiency virus coinfection on the spectrum of liver disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2007
Same author

Thrombin generation time is a novel parameter for monitoring enoxaparin therapy in patients with end-stage renal disease.

Journal of thrombosis and haemostasis : JTH·2006
Same author

Antifactor Xa activity correlates to thrombin generation time, platelet contractile force and clot elastic modulus following ex vivo enoxaparin exposure in patients with and without renal dysfunction.

Journal of thrombosis and haemostasis : JTH·2004
Same journal

Diabetes and the risk of entrapment neuropathies of the upper and lower extremity - A propensity score-matched cohort study.

Journal of diabetes and its complications·2026
Same journal

Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes.

Journal of diabetes and its complications·2026
Same journal

From obesity guideline to diabetes practice: WHO GLP-1 recommendations between promise, uncertainty and global inequity.

Journal of diabetes and its complications·2026
Same journal

Impact of the AWGS2025 criteria on sarcopenia prevalence and microvascular complications in individuals with type 2 diabetes in Japan: a cross-sectional study.

Journal of diabetes and its complications·2026
Same journal

Clinical inertia in patients with type 2 diabetes: A retrospective cohort study using an electronic healthcare database in Japan.

Journal of diabetes and its complications·2026
Same journal

From static lipids to dynamic risk: The role of atherogenic index of plasma in prediabetes.

Journal of diabetes and its complications·2026
See all related articles

Related Experiment Video

Updated: Jan 25, 2026

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.9K

Diabetes mellitus: a hypercoagulable state.

M E Carr1

  • 1Departments of Internal Medicine and Pathology, Medical College of Virginia, Virginia Commonwealth University, Box 980230, Richmond, VA 23298-0230, USA. mcarr@hsc.vcu.edu

Journal of Diabetes and Its Complications
|March 22, 2001
PubMed
Summary
This summary is machine-generated.

Diabetes significantly increases thrombotic death risk, primarily from cardiovascular issues. This review explores how diabetes causes a hypercoagulable state, increasing clotting and reducing clot breakdown.

More Related Videos

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.5K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 19, 2007

6.2K

Related Experiment Videos

Last Updated: Jan 25, 2026

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds
10:49

Doxycycline Loaded Collagen-Chitosan Composite Scaffold for the Accelerated Healing of Diabetic Wounds

Published on: August 21, 2021

4.9K
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

26.5K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 19, 2007

6.2K

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Endocrinology

Background:

  • Diabetes mellitus is a major risk factor for thrombotic events, with 80% of patients dying from thrombosis.
  • Cardiovascular complications account for 75% of these deaths, with cerebrovascular and peripheral vascular events comprising the remainder.
  • The vascular endothelium, crucial for preventing thrombosis, is impaired in diabetes, contributing to a prothrombotic state.

Purpose of the Study:

  • To review the evidence supporting diabetes as a hypercoagulable state.
  • To explore the roles of hyperglycemia and hyperinsulinemia in the development of this prothrombotic condition.

Main Methods:

  • Review of published literature on coagulation, fibrinolysis, and platelet function in diabetes.
  • Analysis of markers for coagulation activation, clotting factor levels, and anticoagulant protein levels.
  • Assessment of fibrinolytic system activity and platelet hyperactivity indicators.

Main Results:

  • Elevated markers of coagulation activation (e.g., prothrombin fragment 1+2, thrombin-antithrombin complexes).
  • Increased plasma levels of multiple clotting factors (fibrinogen, factors VII, VIII, XI, XII, kallikrein, von Willebrand factor) and decreased levels of anticoagulant protein C.
  • Inhibited fibrinolysis due to resistant clot structures and increased plasminogen activator inhibitor type 1 (PAI-1), alongside evidence of platelet hyperactivity.

Conclusions:

  • Diabetes is characterized by a hypercoagulable state, increasing the risk of thrombotic and cardiovascular events.
  • Endothelial dysfunction, coagulation activation, impaired fibrinolysis, and platelet hyperactivity are key contributors.
  • Hyperglycemia and hyperinsulinemia are implicated as potential drivers of these hemostatic abnormalities.